Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
Aakash Desai, Justin F. Gainor, Aparna Hegde, et al.
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 5, pp. 313-319
Open Access | Times Cited: 134

Showing 26-50 of 134 citing articles:

COVID-19's impact on heart and lung transplantation: Citation-based analysis of research output
Nisreen Yaghmour, Dina Alramini, Mohammad Alsarayrah, et al.
World Journal of Transplantation (2025) Vol. 15, Iss. 2
Closed Access
The viral oncogenesis of COVID-19 and its impact on cancer progression, long-term risks, treatment complexities, and research strategies
Moawiah M. Naffaa, Ola A Al-Ewaidat
Exploration of Medicine (2025) Vol. 6
Open Access
Vaccination of cancer patients against COVID-19: towards the end of a dilemma
Avik Mandal, Pritanjali Singh, Arghadip Samaddar, et al.
Medical Oncology (2021) Vol. 38, Iss. 8
Open Access | Times Cited: 23
Impact of COVID‐19 on abdominal organ transplantation: A bibliometric analysis
Badi Rawashdeh, Saif Aldeen AlRyalat, Mohammad Abuassi, et al.
Transplant Infectious Disease (2023) Vol. 25, Iss. 3
Open Access | Times Cited: 8
Multicenter Study of Antibody Seroprevalence against COVID-19 in Patients Presenting to Iranian Cancer Centers after One Year of the COVID-19 Pandemic
Seyed Alireza Javadinia, Mona Ariamanesh, Maryam Nabavifard, et al.
Cancer Investigation (2021) Vol. 40, Iss. 2, pp. 115-123
Closed Access | Times Cited: 20
Impact of Corona-Phobia on Attitudes and Acceptance Towards COVID-19 Vaccine Among Cancer Patients: a Single-Center Study
Di̇lek Erdem, İrem Karaman
Future Oncology (2021) Vol. 18, Iss. 4, pp. 457-469
Open Access | Times Cited: 20
Are patients with cancer at higher risk of COVID-19-related death? A systematic review and critical appraisal of the early evidence
Victoria Freeman, Suzanne Hughes, Chelsea Carle, et al.
Journal of Cancer Policy (2022) Vol. 33, pp. 100340-100340
Open Access | Times Cited: 14
A systematic review and meta-analysis of immune response against first and second doses of SARS-CoV-2 vaccines in adult patients with hematological malignancies
Maryam Noori, Shadi Azizi, Farhan Abbasi Varaki, et al.
International Immunopharmacology (2022) Vol. 110, pp. 109046-109046
Open Access | Times Cited: 14
COVID-19 vaccination and cancer immunotherapy: should they stick together?
Patrick Brest, Baharia Mograbi, Paul Hofman, et al.
British Journal of Cancer (2021) Vol. 126, Iss. 1, pp. 1-3
Open Access | Times Cited: 18
Comparison and impact of COVID-19 for patients with cancer: a survival analysis of fatality rate controlling for age, sex and cancer type
Haiquan Li, Edwin Baldwin, Xiang Zhang, et al.
BMJ Health & Care Informatics (2021) Vol. 28, Iss. 1, pp. e100341-e100341
Open Access | Times Cited: 17
Immune-related adverse events of COVID-19 vaccination in skin cancer patients receiving immune-checkpoint inhibitor treatment
S Strobel, Devayani Machiraju, Katharina A. Kälber, et al.
Cancer Immunology Immunotherapy (2021) Vol. 71, Iss. 8, pp. 2051-2056
Open Access | Times Cited: 17
Effectiveness and safety of COVID-19 vaccination in people with blood cancer
Emma Copland, Jennifer Hirst, Emma Mi, et al.
European Journal of Cancer (2024) Vol. 201, pp. 113603-113603
Open Access | Times Cited: 2
Care without a compass: Including patients with cancer in COVID-19 studies
Christopher R. Friese, Toni K. Choueiri, Narjust Duma, et al.
Cancer Cell (2021) Vol. 39, Iss. 7, pp. 895-896
Open Access | Times Cited: 16
Emerging issues related to COVID-19 vaccination in patients with cancer
Kamal S. Saini, Diogo Martins-Branco, Marco Tagliamento, et al.
Oncology and Therapy (2021) Vol. 9, Iss. 2, pp. 255-265
Open Access | Times Cited: 16
Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors
Benjamin Switzer, John B.A.G. Haanen, Paul Lorigan, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 7, pp. e002835-e002835
Open Access | Times Cited: 16
Cancer or COVID-19? A Review of Recommendations for COVID-19 Vaccination in Cancer Patients
Manit K. Gundavda, Kaival Gundavda
Current Treatment Options in Oncology (2021) Vol. 22, Iss. 10
Open Access | Times Cited: 16
COVID‐19 and the impact on gynecologic cancer care
Ranjit Manchanda, Samuel Oxley, Sadaf Ghaem‐Maghami, et al.
International Journal of Gynecology & Obstetrics (2021) Vol. 155, Iss. S1, pp. 94-101
Open Access | Times Cited: 15
The antibody response of haematological malignancies to COVID-19 infection and vaccination
Nicole A. Seebacher
British Journal of Cancer (2022) Vol. 126, Iss. 5, pp. 691-692
Open Access | Times Cited: 11
Using Behavioral Science to Address COVID-19 Vaccine Hesitancy Among Cancer Survivors: Communication Strategies and Research Opportunities
Robin C. Vanderpool, Anna Gaysynsky, Wen‐Ying Sylvia Chou, et al.
Journal of Behavioral Medicine (2022) Vol. 46, Iss. 1-2, pp. 366-376
Open Access | Times Cited: 11
The impact of the COVID-19 pandemic on palliative care practice: A survey of clinical oncologists
Yu Wang, Yilin Huang, Xiangyu Ma, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 11
A comparative study of the COVID-19 vaccine efficacy among cancer patients: mRNA versus non-mRNA
Andhika Rachman, Anggraini Iriani, Lugyanti Sukrisman, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0281907-e0281907
Open Access | Times Cited: 6
Management of chronic lymphocytic leukemia in Italy during a one year of the COVID‐19 pandemic and at the start of the vaccination program. A Campus CLL report
Antonio Cuneo, Gian Matteo Rigolin, Marta Coscia, et al.
Hematological Oncology (2021) Vol. 39, Iss. 4, pp. 570-574
Open Access | Times Cited: 14
Influence of Health Beliefs on COVID-19 Vaccination among Individuals with Cancer and Other Comorbidities in Puerto Rico
McClaren Rodríguez, Andrea López‐Cepero, Ana P. Ortiz-Martínez, et al.
Vaccines (2021) Vol. 9, Iss. 9, pp. 994-994
Open Access | Times Cited: 14
Haematological malignancies implications during the times of the COVID‑19 pandemic (Review)
Eleni Papakonstantinou, Konstantina Dragoumani, Αspasia Efthimiadou, et al.
Oncology Letters (2021) Vol. 22, Iss. 6
Open Access | Times Cited: 14
Pfizer-BioNTech (BNT162b2), Moderna (mRNA-1273) COVID-19 mRNA vaccines and hypersensitivity reactions
Hannah N Haq, Hafiz T. A. Khan, Haroon Rashid Chaudhry, et al.
Journal of the National Medical Association (2022) Vol. 114, Iss. 6, pp. 601-612
Open Access | Times Cited: 10

Scroll to top